Research Analysts Offer Predictions for Dolby Laboratories, Inc.’s Q2 2025 Earnings (NYSE:DLB)

Dolby Laboratories, Inc. (NYSE:DLB – Get Rating) – Equities researchers at Zacks Research decreased their Q2 2025 earnings per share (EPS) estimates for shares of Dolby Laboratories in a note issued to investors on Monday, May 22nd. Zacks Research analyst V. Doshi now anticipates that the electronics maker will earn $0.79 per share for the quarter, down from their previous estimate of $0.85. The consensus estimate for Dolby Laboratories’ current full-year earnings is $2.47 per share.

Other analysts have also recently issued research reports about the stock. Tigress Financial restated a “buy” rating and issued a $116.00 price objective on shares of Dolby Laboratories in a research report on Friday, April 14th. Rosenblatt Securities raised their target price on shares of Dolby Laboratories from $85.00 to $90.00 and gave the company a “buy” rating in a research note on Friday, February 3rd. StockNews.com started coverage on shares of Dolby Laboratories in a research report on Thursday, May 18th. They set a “buy” rating for the company. Finally, TheStreet upgraded shares of Dolby Laboratories from a “c” rating to a “b” rating in a research report on Friday, February 3rd. One investment analyst has rated the stock with a hold rating and three have assigned a buy rating to the stock. According to data from MarketBeat.com, Dolby Laboratories currently has an average rating of “Moderate Buy” and an average target price of $103.00.

Dolby Laboratories Stock Performance

NYSE:DLB opened at $82.19 on Wednesday. The stock’s fifty day moving average price is $83.78 and its two-hundred day moving average price is $78.79. Dolby Laboratories has a 52-week low of $61.55 and a 52-week high of $88.06. The company has a market cap of $7.85 billion, a price-to-earnings ratio of 33.28, a P/E/G ratio of 2.09 and a beta of 1.00.

Dolby Laboratories Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Tuesday, May 23rd. Investors of record on Tuesday, May 16th were issued a $0.27 dividend. The ex-dividend date of this dividend was Monday, May 15th. This represents a $1.08 dividend on an annualized basis and a dividend yield of 1.31%. Dolby Laboratories’s dividend payout ratio is presently 43.72%.

Insider Buying and Selling

In other Dolby Laboratories news, CEO Kevin J. Yeaman sold 9,030 shares of the stock in a transaction dated Tuesday, May 16th. The shares were sold at an average price of $83.65, for a total value of $755,359.50. Following the completion of the sale, the chief executive officer now owns 51,879 shares in the company, valued at approximately $4,339,678.35. The transaction was disclosed in a document filed with the SEC, which is available at this link. In other news, CEO Kevin J. Yeaman sold 30,779 shares of Dolby Laboratories stock in a transaction on Tuesday, April 11th. The shares were sold at an average price of $84.44, for a total transaction of $2,598,978.76. Following the completion of the sale, the chief executive officer now directly owns 51,879 shares of the company’s stock, valued at approximately $4,380,662.76. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CEO Kevin J. Yeaman sold 9,030 shares of Dolby Laboratories stock in a transaction on Tuesday, May 16th. The stock was sold at an average price of $83.65, for a total transaction of $755,359.50. Following the sale, the chief executive officer now directly owns 51,879 shares of the company’s stock, valued at $4,339,678.35. The disclosure for this sale can be found here. Insiders have sold 56,087 shares of company stock worth $4,716,204 in the last quarter. Insiders own 39.25% of the company’s stock.

Hedge Funds Weigh In On Dolby Laboratories

A number of large investors have recently added to or reduced their stakes in DLB. JPMorgan Chase & Co. boosted its stake in shares of Dolby Laboratories by 31.4% during the 1st quarter. JPMorgan Chase & Co. now owns 126,310 shares of the electronics maker’s stock valued at $9,880,000 after purchasing an additional 30,158 shares in the last quarter. Raymond James Financial Services Advisors Inc. boosted its stake in shares of Dolby Laboratories by 4.3% during the 1st quarter. Raymond James Financial Services Advisors Inc. now owns 10,186 shares of the electronics maker’s stock valued at $797,000 after purchasing an additional 418 shares in the last quarter. Private Advisor Group LLC boosted its stake in shares of Dolby Laboratories by 7.8% during the 1st quarter. Private Advisor Group LLC now owns 6,277 shares of the electronics maker’s stock valued at $491,000 after purchasing an additional 456 shares in the last quarter. MetLife Investment Management LLC bought a new stake in shares of Dolby Laboratories during the 1st quarter valued at about $100,000. Finally, Great West Life Assurance Co. Can boosted its stake in shares of Dolby Laboratories by 3.4% during the 1st quarter. Great West Life Assurance Co. Can now owns 4,954 shares of the electronics maker’s stock valued at $409,000 after purchasing an additional 164 shares in the last quarter. Hedge funds and other institutional investors own 82.30% of the company’s stock.

About Dolby Laboratories

(Get Rating)

Dolby Laboratories, Inc engages in the provision of audio and imaging technologies. It transforms entertainment and communications for content playback in movies, television, music, and gaming. Its products include Cinema Imaging Products, Cinema Audio Products, and other products such as 3-D kits, broadcast hardware and software, monitors, and solutions for hearing impaired consumers.